presentation file 510add1e df9c 487f a1b3 0b92ac10505a

7/29/2019 Presentation File 510add1e Df9c 487f a1b3 0b92ac10505a

1/9

SAFENCLEAR

Dr. Anne

McIntosh

Bio-smart Surgical Face Maskfor Todays Challenges


2/9

Problems with Surgical Masks

Obstruct facial

expressions and lip

movements

Scare and stresschildren unnecessarily

Not antibacterial and

offer little protection

against germs

Worn by the healthy

healthcare provider, not

the contagious patient


3/9

Did You Know

35% of the meaning

from communication

is derived from the

words we use 65% of the meaning

comes from the

nonverbal cues

- Dr. Albert Mehrabian,1965

We communicate better if we can see the

speaker


4/9

The Solution: SafeNClear

Transparent, antibacterial facemask has wide appeal

Children prefer the transparency in the midst of the sterilityof hospital, white scrubs, garbed doctors, and anxiety withtheir medical issue(s).

Hearing-impaired patients depend on lip-reading tounderstand conversations and to follow verbal commands.

NOTE: John Hopkins University- 1 in 5 Americans has

hearing loss to the extent that communication is affected.

Elderly patients prefer to see the people they areinteracting with in conversations.

NOTE: 11,000 baby boomers turn 65 each day.

Law Enforcement, Military, Firefighters/EMS who have upclose contact with public can benefit.

Dental, Optical, and Healthcare providers will getprotection.


5/9

The Solution: The

SafeNClear

Transparent,

antibacterial

mask:

Constructed fromclear,

polyethelyne film;

2 or more layers

Treated withantibacterial and

antiviral agents

Perforated to

ensure


6/9


7/9

SafeNClear revolutionizing

healthcare

Pharmaceutical therapies such as antibiotics

are becoming less effective against super-bugs;

the more protection we can provide in products

worn on the outside of the body, the less

medication (and side effects) to deal with on theinside of the body. This mask can provide

protection against bacterial and viral pathogens

on contact and reduce human-to-human

transmission.


8/9

Work done and new

markets

American and European patent applications

filed.

Prototype alpha with preliminary clinical testing

results.

New markets not tapped include: (1)

healthcare field masking the patients, (2) mass

transportation industries such as: airline,subways, bus, trains, (3) enclosed populations

such as daycare centers, college dorms,

military installations, (4) employees exposed to

public such as postal workers, mall


9/9

Moving forward.

SafeNClear is seeking capital funds to

implement Phase II to commercialize

SafeNClear .

Dont take chances with germs and viruses. Be

smart- use SafeNClear to protect you and

your family against todays germs.

Clear Communication. Advanced Protection.

presentation file 510add1e df9c 487f a1b3 0b92ac10505a

Documents